Sæmundur Rögnvaldsson, MD, PhD
@saemundurmd
IM trainee at Landspítali in Reykjavik and postdoctoral researcher at UI. Involved with the iStopMM trial as a Core Team member. Opinions and Tweets are my own.
ID: 1054784756704010241
23-10-2018 17:20:57
146 Tweet
288 Takipçi
194 Takip Edilen
COVID-19 vaccination does not increase the risk of MGUS progression. Important data from the iStopMM trial by Robert Palmason Sigurdur Kristinsson #ASH22 #mmsm
Colsevelam for lenalidomide associated diarrhea: high response rate (88%) and importantly, no effect on lenalidomide PK. Come check it out! #ASH22 #mmsm MSKHemOncTrials
What a brilliant team! The iStopMM Team! Our pleasure seeing you here at #ASH22 #IMFASH22 #myeloma International Myeloma Foundation Michael Tuohy NickL_MyelomaLiving Sæmundur Rögnvaldsson, MD, PhD Brian Durie, M.D. Keep up the outstanding work!
And this is how you do a fantastic educational on myeloma at #ASH22 ! Fabulous session by Sigrun Thorsteinsdottir Caitlin Costello, MD Yvonne Efebera Well done ASH! Congrats #woMMen
The single MOST important study presented at #ASH22 that can impact SO many patients. Please don’t routinely order SPEP/light chains in patients with autoimmune diseases. Such an honor to take a picture with Ingigerður Sólveig by her incredible poster Sigurdur Kristinsson iStopMM #mmsm
The International Myeloma Foundation support group leader team at #ASH22 had the pleasure of listening to @eliaseythorsson present on this new excellent tool. Thank you! iStopMM #IMFASH22 #myeloma Sæmundur Rögnvaldsson, MD, PhD Sigurdur Kristinsson
Our article 'Prevalence of smoldering multiple myeloma based on nationwide screening' is out in Nature Medicine. A lot of work from the great iStopMM team behind this project ✨️ Sigurdur Kristinsson Sæmundur Rögnvaldsson, MD, PhD Malin Hultcrantz MD PhD @TBSsteharding C. Ola Landgren, M.D. nature.com/articles/s4159…
Excellent presentations by rising star Sigrun Thorsteinsdottir & 2023 IMWG Robert Kyle Lifetime Achievement awardee marivi mateos at #IMWG Summit to facilitate discussion for how best to screen & manage MGUS and SMM. Shaji Kumar Vincent Rajkumar Brian Durie, M.D. Rafat Abonour
And guess what!? They all got an abstract achievement award! #ASH2023 If you zoom in you might see how happy they are! Sæmundur Rögnvaldsson, MD, PhD Jón Þórir Óskarsson Sigrun Thorsteinsdottir Þórir Long iStopMM
Great presentation by Theresia Akhlaghi showing the importance of dynamic risk assessment in SMM #ASH23 #mmsm Malin Hultcrantz MD PhD
🧵1/ Our paper is out! A new study from the iStopMM team in JAMA Oncology shows how revising free light chain (FLC) reference intervals can reduce false positives for light chain MGUS (LC-MGUS). Let’s break it down 👇 jamanetwork.com/journals/jamao…